Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Posture disorders in patients with multiple sclerosis.]
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Recommendations for the management of multiple sclerosis relapses.
MAIT cells in autoimmunity.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
Neuromuscular taping in multiple sclerosis. A pilot study.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Major stressful life events in adulthood and risk of multiple sclerosis.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
A randomized trial of stress management for the prevention of new brain lesions in MS.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »